Grayslake, IL, United States of America

Arturo Perez Medrano


Average Co-Inventor Count = 7.2

ph-index = 2

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2002-2011

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Arturo Perez Medrano

Introduction

Arturo Perez Medrano is an accomplished inventor based in Grayslake, Illinois. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that interact with cannabinoid receptors. With a total of two patents to his name, his work is recognized for its potential impact on medical treatments.

Latest Patents

One of his latest patents involves compounds as cannabinoid receptor ligands. This patent discloses compounds of a specific formula, wherein various components are defined in the specification. The patent also describes pharmaceutical compositions that comprise these compounds, along with methods for treating various conditions and disorders using these innovative formulations. Another notable patent focuses on aminal diones as potassium channel openers, showcasing his diverse expertise in medicinal chemistry.

Career Highlights

Arturo Perez Medrano is currently employed at Abbott Laboratories Corporation, a leading global healthcare company. His role at Abbott allows him to work on cutting-edge research and development projects that aim to improve patient outcomes through innovative therapies.

Collaborations

Throughout his career, Arturo has collaborated with esteemed colleagues, including William A. Carroll and Teodozyj Kolasa. These collaborations have likely contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Arturo Perez Medrano's contributions to the field of pharmaceuticals through his innovative patents highlight his role as a significant inventor. His work continues to pave the way for advancements in medical treatments and therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…